Pantai Premier Pathology (PPP) celebrated its 25th anniversary on 21 December 2022, with an appreciation dinner for staff and partners attended by IHH Chairman Tan Sri Mohammed Azlan and IHH Managing Director & CEO Dr Kelvin Loh.
Additionally, PPP recently announced two new collaborations with bioMérieux and MiRXES to strengthen our lab diagnostics capabilities.
Under the MOU with French biotech MNC bioMérieux, PPP will set up an Antimicrobial Stewardship Centre of Excellence to promote the responsible use of antibiotics and preserve the efficacy of these drugs for the present and future generations. PPP plays a crucial role in supporting the efforts to contain antimicrobial resistance by identifying the pathogen responsible for a patient's infection and conducting antimicrobial susceptibility testing to determine the optimal antimicrobial therapy for the patient.
The collaboration with MiRXES seeks to provide accessible and affordable molecular oncology testing to Malaysians which includes the early detection of gastric cancer via blood test and DNA testing.
These partnerships are critical towards providing our patients with the best care and clinical outcomes. We look forward to further serving our communities through these partnerships.
Congratulations to the PPP team on its Silver Jubilee and the two MOUs!
Related Stories
Pantai Hospital Melaka Launches Malaysia's First Smart Fridge Hub for Oncology Medicines
Pantai Hospital Melaka, part of IHH Healthcare, has become the first hospital in Malaysia to launch a Smart Fridge micro-inventory hub for selected oncology medicines, marking a significant step forward in improving access to cancer treatment.
IHH Healthcare Marks Three Years of Partnership With Singapore Sea Regatta
Gleneagles Hospital Hong Kong Launches TeleCare SmartHub with SmarTone
IHH Healthcare Singapore and AIA Singapore Partner to Advance Value-based Care
IHH Singapore Advances the Conversation on Healthspan and Longevity
